September
Ex-Pfizer staff create new UK firm
Former Pfizer employees have created a research networking firm to be based in Kent, England, at a site the pharmaceutical company had previously announced it was to vacate
01 Sep 2011
AstraZeneca sells dental business
The sale of pharmaceutical firm AstraZeneca's dental business, Astra Tech, to Dentsply for $1.8bn has been completed
01 Sep 2011
Sanofi to make generic Lipitor
Sanofi is to launch a generic version of Pfizer's blockbuster anticholesterol Lipitor, which is due to lose patent protection in 2012
01 Sep 2011
New EU approval for Roche’s Tarceva
The European Commission has approved Roche's cancer treatment Tarceva for first-line use in patients with a certain type of non-small cell lung cancer
01 Sep 2011
The next healthcare paradigm shift
Public relations can help the move from a paternalistic to a patient-centric system
15 Sep 2011
Further EU approval for Novartis' Afinitor
Novartis' cancer therapy Afinotor has been granted an additional EU approval for use in the treatment of patients with an advanced form of pancreatic cancer
05 Sep 2011
Crestor fails to outshine Lipitor
AstraZeneca's cholesterol drug Crestor has failed to show an advantage over its rival Lipitor in study data released by the pharmaceutical company
05 Sep 2011
WHO and FIP sign joint initiative for TB
The World Health Organisation and the International Pharmaceutical Federation has signed a joint statement to strengthen the role of pharmacists in tuberculosis care and control
05 Sep 2011
AZ to develop partnership prospects
AstraZeneca has appointed Katja Toon as communications director, externalisation, to lead the pharmaceutical company's dealings with other firms and organisations
05 Sep 2011
Amakem raises €18m for glaucoma treatment
Amakem, the Belgium-based pharmaceutical company, has raised €18m to advance its lead glaucoma candidate to clinical proof-of-concept
06 Sep 2011